Healthcare provider profile · identity verified

Thomas M.G. Meyer, MD

Internal Medicine · RED WING, MN · NPI 1821064700

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	667	213
Levothyroxine Sodium	Levothyroxine Sodium	374	103
Furosemide	Furosemide	361	108
Lisinopril	Lisinopril	344	117
Metoprolol Succinate	Metoprolol Succinate	335	104
Amlodipine Besylate	Amlodipine Besylate	284	97
Losartan Potassium	Losartan Potassium	266	85
Omeprazole	Omeprazole	187	64
Eliquis	Apixaban	179	47
Metformin Hcl	Metformin Hcl	169	57
Potassium Chloride	Potassium Chloride	169	61
Tamsulosin Hcl	Tamsulosin Hcl	164	57
Warfarin Sodium	Warfarin Sodium	163	48
Pravastatin Sodium	Pravastatin Sodium	148	49
Gabapentin	Gabapentin	146	53
Simvastatin	Simvastatin	142	49
Metoprolol Tartrate	Metoprolol Tartrate	140	45
Alendronate Sodium	Alendronate Sodium	124	50
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	124	47
Rosuvastatin Calcium	Rosuvastatin Calcium	124	42
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	103	32
Ozempic	Semaglutide	98	25
Fluticasone Propionate	Fluticasone Propionate	97	42
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	97	32
Allopurinol	Allopurinol	95	34
Duloxetine Hcl	Duloxetine Hcl	94	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	87	30
Spironolactone	Spironolactone	85	22
Hydrochlorothiazide	Hydrochlorothiazide	84	33
Prednisone	Prednisone	84	37
Famotidine	Famotidine	79	28
Atenolol	Atenolol	73	25
Doxazosin Mesylate	Doxazosin Mesylate	72	22
Torsemide	Torsemide	61	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	60	20
Metformin Hcl Er	Metformin Hcl	60	22
Pantoprazole Sodium	Pantoprazole Sodium	58	21
Trazodone Hcl	Trazodone Hcl	56	18
Albuterol Sulfate Hfa	Albuterol Sulfate	55	29
Sertraline Hcl	Sertraline Hcl	53	19
Tramadol Hcl	Tramadol Hcl	49	25
Escitalopram Oxalate	Escitalopram Oxalate	47	13
Carvedilol	Carvedilol	44	17
Celecoxib	Celecoxib	44	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	16
Clopidogrel	Clopidogrel Bisulfate	39	15
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	36	13
Finasteride	Finasteride	35	11
Lamotrigine	Lamotrigine	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Mirtazapine	Mirtazapine	33	14
Glimepiride	Glimepiride	32	15
Chlorthalidone	Chlorthalidone	31	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Topiramate	Topiramate	31	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	31	13
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Jardiance	Empagliflozin	30	12
Triamcinolone Acetonide	Triamcinolone Acetonide	30	17
Xarelto	Rivaroxaban	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	11
Ipratropium Bromide	Ipratropium Bromide	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Nystatin	Nystatin	26	13
Azithromycin	Azithromycin	21	14
Nitroglycerin	Nitroglycerin	21	15
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	14
Ezetimibe	Ezetimibe	19	suppressed
Ketoconazole	Ketoconazole	19	11
Ventolin Hfa	Albuterol Sulfate	19	12
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Estradiol	Estradiol	17	11
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Pregabalin	Pregabalin	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Alprazolam	Alprazolam	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Valsartan	Valsartan	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Humalog	Insulin Lispro	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	13	suppressed
Pen Needle	Pen Needle, Diabetic	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Lidocaine	Lidocaine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Praluent Pen	Alirocumab	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error